Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

May 22 2001
Washington, D.C. (May 22, 2001) – Bernice Welles, M.D., will speak on behalf of the Biotechnology Industry Organization Wednesday at a Senate hearing to...
May 17 2001
WASHINGTON, D.C. (May 17, 2001) – Skyrocketing gasoline, home heating oil and natural gas prices underscore the importance of developing renewable energy...
May 16 2001
WASHINGTON, D.C. (May 16, 2001) -- It is likely that PresidentBush and Vice President Cheney will include bioenergy development in their new energy policy....
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the...
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in...
May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the...
May 11 2001
WASHINGTON, D.C. (May 11, 2001) – The U.S. Senate passed a resolution (attached) declaring May 13 – 20 National Biotechnology Week, thereby recognizing...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement after congressional...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Lila Feisee, director of government relations and intellectual property at the Biotechnology Industry Organization (BIO),...


Biotechnology News

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), announced that company representatives will participate in several investor conferences in...

August 27, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, Chief Executive Officer, and Andrew A. Hindman, Chief Business...

August 27, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based...

August 27, 2014

HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc., a biotechnology company focused on developing safer and more effective cellular immunotherapies, today announced...

August 27, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Morgan Stanley Global Healthcare Conference...